Freedom Wealth Alliance’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-150
Closed -$4.24K 94
2022
Q4
$4.24K Buy
+150
New +$4.76K 0.01% 359

Other funds holding ARKG

Freedom Wealth Alliance's ARKG Position: Q1 2023 in Review

Freedom Wealth Alliance sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 150 shares — an estimated $4.24K sold.

Freedom Wealth Alliance first reported a position in ARKG in Q4 2022 and held it in 1 quarter. The position peaked at $4.24K in Q4 2022. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • Freedom Wealth Alliance reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • Freedom Wealth Alliance sold 150 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $4.24K.
  • Freedom Wealth Alliance first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 1 quarter.
  • Freedom Wealth Alliance's ARK Genomic Revolution ETF position peaked at $4.24K in Q4 2022.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Freedom Wealth Alliance's 13F filing for Q1 2023, filed 25 Apr 2023.